Alnylam Pharmaceuticals
ALNY
#854
Rank
โ‚ฌ26.12 B
Marketcap
195,22ย โ‚ฌ
Share price
0.59%
Change (1 day)
-46.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company